Molecular diagnosis of Epstein-Barr virus infections (Q45352227)

13 December 2017

title

Molecular diagnosis of Epstein-Barr virus infections (English)

1 reference

13 December 2017

1 reference

Steven Ft Thijsen

1 reference

13 December 2017

Marjolein Pd Deege

series ordinal

1 reference

13 December 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

Expert Opinion on Medical Diagnostics

13 December 2017

published in

1 reference

13 December 2017

1 reference

13 December 2017

1 reference

13 December 2017

page(s)

21-31

1 reference

Detection of Epstein-Barr virus in salivas and throat washings in healthy adults and children

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Sequence analysis of EBV DNA isolated from mouth washings and PBMCs of healthy individuals and blood of EBV-LPD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

A prospective clinical study of Epstein-Barr virus and host interactions during acute infectious mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Detection of Epstein-Barr virus, but not human herpesvirus 8, DNA in cervical secretions from Swedish women by real-time polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Viruses in the mammalian male genital tract and their effects on the reproductive system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

A study of risk factors for acquisition of Epstein-Barr virus and its subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Epstein-Barr virus (EBV) DNA in sera of patients with primary EBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Detailed kinetics of EBV-specific CD4+ and CD8+ T cells during primary EBV infection in a kidney transplant patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Viruses use stealth technology to escape from the host immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

The ins and outs of EBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Epstein-Barr virus: evasive maneuvers in the development of PTLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Persistence of the Epstein-Barr virus and the origins of associated lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Epstein-Barr virus and survival after Hodgkin disease in a population-based series of women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Prevention and treatment of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of bone marrow and solid organ transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

The role of EBV in post-transplant malignancies: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Epstein-Barr virus-recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Severe Epstein-Barr virus-associated hemophagocytic syndrome in six adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

A possible role for Epstein-Barr virus in the pathogenesis of pleural effusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Clinical and laboratory presentation of EBV positive infectious mononucleosis in young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

A systematic study of Epstein-Barr virus serologic assays following acute infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

False-positive IgM antibody tests for cytomegalovirus in patients with acute Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Routine Epstein-Barr virus diagnostics from the laboratory perspective: still challenging after 35 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Clinical evaluation of patients with infectious mononucleosis and development of antibodies to the R component of the Epstein-Barr virus-induced early antigen complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Clinical virology in real time

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Quantitation of viral load using real-time amplification techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Rapid detection of Epstein-Barr virus DNA by loop-mediated isothermal amplification method

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

In-house nucleic acid amplification assays in research: how much quality control is needed before one can rely upon the results?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Verification and validation of diagnostic laboratory tests in clinical virology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Epstein-Barr Virus (EBV) DNA in plasma is not encapsidated in patients with EBV-related malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Persistently high Epstein-Barr virus (EBV) loads in peripheral blood lymphocytes from patients with chronic active EBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Analysis of immune activation and clinical events in acute infectious mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

The role of Epstein-Barr virus in acute and chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Is EBV persistence in vivo a model for B cell homeostasis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

A novel form of Epstein-Barr virus latency in normal B cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Anatomical mapping of human herpesvirus reservoirs of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Real-time polymerase chain reaction (RQ-PCR) for the monitoring of Epstein-Barr virus (EBV) load in peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Detection and quantification of cell-free Epstein-Barr virus by polymerase chain reaction and subsequent DNA enzyme immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Detection of herpesvirus DNA in the serum of immunocompetent children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Toward standardization of Epstein-Barr virus DNA load monitoring: unfractionated whole blood as preferred clinical specimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Routine use of real-time quantitative PCR for laboratory diagnosis of Epstein-Barr virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Limitations of polymerase chain reaction testing for diagnosing acute Epstein-Barr virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Clinical evaluation of a quantitative real time polymerase chain reaction assay for diagnosis of primary Epstein-Barr virus infection in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Measurement by the polymerase chain reaction of the Epstein-Barr virus load in infectious mononucleosis and AIDS-related non-Hodgkin's lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Diagnostic value of measuring Epstein-Barr virus (EBV) DNA load and carcinoma-specific viral mRNA in relation to anti-EBV immunoglobulin A (IgA) and IgG antibody levels in blood of nasopharyngeal carcinoma patients from Indonesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Nasopharyngeal brush biopsies and detection of nasopharyngeal cancer in a high-risk population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Quantitative analysis of circulating cell-free Epstein-Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Limitations of EBV-PCR monitoring to detect EBV associated post-transplant lymphoproliferative disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Preemptive diagnosis and treatment of Epstein-Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Adoptive immunotherapy for Epstein-Barr virus-related lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Quantitative analysis of EBV-specific CD4/CD8 T cell numbers, absolute CD4/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Impaired recovery of Epstein-Barr virus (EBV)--specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Epstein-Barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Detection of cell-free Epstein-Barr virus DNA in serum during acute infectious mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

Infectious Mononucleosis, Childhood Social Environment, and Risk of Hodgkin Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.21

21 January 2018

Identifiers

DOI

10.1517/17530059.2.1.21

1 reference

release_nq3zkk5bxvfshd3chdldeeou3q

13 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nq3zkk5bxvfshd3chdldeeou3q

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference